Integrated RF and B-mode Deformation Analysis for 4D Stress Echocardiography
NCT ID: NCT02327455
Last Updated: 2023-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-07-31
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stress Dobutamine Echocardiographic 4DE Image System
Subjects will undergo their clinically indicated stress dobutamine echocardiographic studies using our standard clinical graded dobutamine stress imaging protcol, employing the iE33 4DE system.
Stress Dobutamine Echocardiographic using 4DE System
Subjects will undergo their clinically indicated stress dobutamine echocardiographic studies using our standard clinical graded dobutamine stress imaging protcol, employing the iE33 4DE system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stress Dobutamine Echocardiographic using 4DE System
Subjects will undergo their clinically indicated stress dobutamine echocardiographic studies using our standard clinical graded dobutamine stress imaging protcol, employing the iE33 4DE system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provide written informed consent to participate in the study
* Availability for repease rest/stress TTE within on eweek of clinically indicated study
Exclusion Criteria
* Unstable hemodynamics that would not allow for repease rest/stress dobutamine transthoracic imaging
* Recurrent life threatening arrhythmias
* Heart rate \>110 BPM
* Inadequate windows for transthoracic imagine
* Patients that have a narrow-angle glaucoma (contraindication for atropine)
* Change in cardiac medications or management including, coronary revascularization beween intial and repeat TTE study.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Albert Sinusas, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R01HL0121226
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
1406014091
Identifier Type: -
Identifier Source: org_study_id